Your browser doesn't support javascript.
loading
The priming induction regimen of HAG as a low dose chemotherapy strategy in AML clonal evolution.
Chen, AiLi; Yang, JingYi; Hu, ShaoYan; Wang, Qian-Fei.
Afiliação
  • Chen A; Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, 100101, China.
  • Yang J; Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, 100101, China.
  • Hu S; The Children's Hospital of Soochow University, Suzhou, 215003, China. hsy139@126.com.
  • Wang QF; Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, 100101, China. wangqf@big.ac.cn.
Sci China Life Sci ; 58(12): 1302-5, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26588914
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Evolução Clonal Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Evolução Clonal Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article